Bispecific Antibody Effective in Untreated Follicular Lymphoma

(MedPage Today) — At the recent American Society of Hematology (ASH) annual meeting, phase II data were presented on a bispecific antibody for patients with previously untreated follicular lymphoma with a high tumor burden.
In this MedPage Today…

Source link : https://www.medpagetoday.com/meetingcoverage/ashvideopearls/119131

Author :

Publish date : 2025-12-22 17:08:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

Bispecific Antibody Effective in Untreated Follicular Lymphoma

Trump Announces Lower Drug Price Deals With 9 Pharmaceutical Companies

Next-Gen Oral SERD Cuts Recurrence Risk in Early Breast Cancer

Related Posts

Is Art the Missing Tool From Modern Healthcare?

Adding Tucatinib in First-Line Maintenance Boosts PFS in HER2-Positive Breast Cancer

Next-Gen Oral SERD Cuts Recurrence Risk in Early Breast Cancer

Trump Announces Lower Drug Price Deals With 9 Pharmaceutical Companies

Polatuzumab-Based Combination Continues to Impress in Real-World DLBCL Analyses

Sniffing Out the Optimal Radiation Dose for Head and Neck Cancer

Is Art the Missing Tool From Modern Healthcare?

Adding Tucatinib in First-Line Maintenance Boosts PFS in HER2-Positive Breast Cancer

Next-Gen Oral SERD Cuts Recurrence Risk in Early Breast Cancer

Bispecific Antibody Effective in Untreated Follicular Lymphoma

Trump Announces Lower Drug Price Deals With 9 Pharmaceutical Companies

Polatuzumab-Based Combination Continues to Impress in Real-World DLBCL Analyses

Sniffing Out the Optimal Radiation Dose for Head and Neck Cancer

Fellow Nurses: Did You (or Will You) Go to Your Staff Christmas Party?

Categories

Archives